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mechanisms of insecticide resistance 
in Anopheles gambiae in Faranah, Guinea
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Abstract 
Background: In recent years, the scale-up of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) 
has greatly reduced malaria transmission. However, malaria remains a global public health concern with the major-
ity of the disease burden in sub-Saharan Africa. Insecticide resistance is a growing problem among Anopheles vector 
populations, with potential implications for the continued effectiveness of available control interventions. Improved 
understanding of current resistance levels and underlying mechanisms is essential to design appropriate manage-
ment strategies and to mitigate future selection for resistance.
Methods: Anopheles gambiae sensu lato mosquitoes were collected from three villages in Faranah Prefecture, Guinea 
and their levels of susceptibility to seven insecticides were measured using CDC resistance intensity bioassays. Syner-
gist assays with piperonyl butoxide (PBO) were also undertaken to assess the role of elevated mixed-function oxidases 
in resistance. Five hundred and sixty-three mosquitoes underwent molecular characterization of vector species, 
presence of target site mutations (L1014F kdr, N1575Y and G119S Ace-1), Plasmodium falciparum infection, and relative 
expression of three metabolic genes (CYP6M2, CYP6P3 and GSTD3).
Results: In Faranah, resistance to permethrin and deltamethrin was observed, as well as possible resistance to ben-
diocarb. All assayed vector populations were fully susceptible to alpha-cypermethrin, pirimiphos-methyl, clothianidin 
and chlorfenapyr. Plasmodium falciparum infection was detected in 7.3% (37/508) of mosquitoes tested. The L1014F 
kdr mutation was found in 100% of a sub-sample of 60 mosquitoes, supporting its fixation in the region. The N1575Y 
mutation was identified in 20% (113/561) of individuals, with ongoing selection evidenced by significant devia-
tions from Hardy–Weinberg equilibrium. The G119S Ace-1 mutation was detected in 62.1% (18/29) of mosquitoes 
tested and was highly predictive of bendiocarb bioassay survival. The metabolic resistance genes, CYP6M2, CYP6P3 
and GSTD3, were found to be overexpressed in wild resistant and susceptible An. gambiae sensu stricto populations, 
compared to a susceptible G3 colony. Furthermore, CYP6P3 was significantly overexpressed in bendiocarb survivors, 
implicating its potential role in carbamate resistance in Faranah.
Conclusions: Identification of intense resistance to permethrin and deltamethrin in Faranah, is of concern, as the 
Guinea National Malaria Control Programme (NMCP) relies exclusively on the distribution of pyrethroid-treated LLINs 
for vector control. Study findings will be used to guide current and future control strategies in the region.
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Background
Despite impressive progress made towards the control 
and elimination of malaria, this disease remains the lead-
ing cause of morbidity and mortality in the tropics, where 
it is estimated to have resulted in the deaths of approxi-
mately 435,000 individuals in 2017 [1]. Between 2010 
and 2017, global malaria incidence has fallen by approxi-
mately 18% globally (72 to 59 cases per 1000 at risk) and 
by 20% in the World Health Organization African region 
[1], which still bears the greatest disease burden [2]. 
Malaria deaths have been decreasing annually, largely due 
to the scale-up of long-lasting insecticidal nets (LLINs) 
[3] and implementation of indoor residual spraying (IRS) 
[2]. However, progress has stalled in some areas, with an 
increase of 2 million cases from 2016 to 2017 [1].
Long-term intensive insecticide use to control agri-
cultural pests and disease vectors has resulted in the 
selection of resistance in many insect species [4]. 
The widespread use of dichlorodiphenyltrichloroeth-
ane (DDT) in the 1950–1960s, followed by the recent 
increase in distribution of LLINs impregnated with pyre-
throids, and the broad use of the same insecticides in the 
agricultural industry has led to the development of resist-
ance in mosquito populations worldwide [5]. This resist-
ance poses a major threat to malaria control [4], where 
vector control is reliant primarily on insecticide-based 
interventions [6]. Of the 80 malaria-endemic countries 
for which data are available from 2010 onwards, 68 coun-
tries detected decreased susceptibility to at least one 
insecticide among vector populations, with 57 countries 
reporting resistance to two or more chemical classes [1].
In Guinea, malaria remains one of the most significant 
diseases of public health importance, with 92% of infec-
tions caused by Plasmodium falciparum [7]. The national 
malaria prevalence is approximately 15%, reaching up to 
25% in Faranah Prefecture [8]. Guinea’s tropical climate 
allows for year-round malaria transmission, with peak 
transmission from July through to October in most areas. 
The Guinean national vector control strategy focuses 
almost exclusively on the distribution of LLINs, with IRS 
occurring in only 1.7% of households, primarily those of 
workers engaged in mining operations [9]. The United 
States President’s Malaria Initiative (PMI) estimates that 
intervention coverage remains low, with only 48% of 
households owning at least one insecticide-treated net 
(ITN) per every two members [9]. Given the reliance 
on LLINs for malaria control, the detection of nation-
wide pyrethroid resistance is of concern [10]. In order to 
safeguard malaria control efforts in the country, current 
insecticide resistance levels and underlying mechanisms 
were characterized among vector populations, to design 
appropriate management strategies and mitigate future 
selection for resistance.
Methods
Study sites and mosquito collections
Human landing catches (HLCs) were conducted at 
three sites in Faranah Prefecture (Fig.  1). The villages 
of Balayani (10.1325, − 10.7443), Foulaya (10.144633, 
− 10.749717), and Tindo (9.9612230, − 10.7016560) were 
selected, due to their high malaria prevalence, and were 
visited every other day until a sufficient sample size for 
testing was acquired. Following consent from the house-
hold owner, two to three fieldworkers, positioned outside 
of the house, collected mosquitoes landing and attempt-
ing to feed on their exposed legs and feet from 18.00 to 
07.00. Mosquitoes were transported back to the insectary 
in Faranah and provided with 10% sucrose solution prior 
to bioassay testing.
Larval collections were also performed in Faranah 
(10.042423, − 10.740980), at sites selected through active 
searching and/or known to have been productive in pre-
vious years. Larvae and pupae were collected using lar-
val dippers, ladles, buckets, and pans. Collections were 
then transported back to the insectary in Faranah where 
they were fed on ground fish food  (TetraMin® Tropical 
Fish Food Flakes). Pupae were removed on a daily basis, 
placed in plastic cups, and transferred to mosquito cages. 
Emerging adult mosquitoes were provided 10% sucrose 
solution prior to bioassay testing. All mosquito samples 
were collected between 25th June and 20th July 2018, at 
the start of the long rainy season.
CDC resistance intensity and synergist bioassays
Centers for Disease Control and Prevention bottle bio-
assays were performed using 250  mL Wheaton bottles 
with adult female mosquitoes of varying ages caught in 
HLCs from the three villages (each village was tested 
separately), or 2–5-day old female mosquitoes raised 
from larvae in the insectary. Mosquitoes collected using 
different methods were tested separately in bioassays. 
Bioassays were performed at the Centre de Santé Mar-
ché in Faranah; mosquitoes were held in the insectary 
for no more than 48  h prior to testing. Following CDC 
guidelines, bottles were coated with alpha-cypermethrin 
(12.5  μg/bottle), deltamethrin (12.5  μg/bottle), perme-
thrin (21.5 μg/bottle), and bendiocarb (12.5 μg/bottle) at 
1, 2, 5, and 10 times the diagnostic dose, and with pirimi-
phos-methyl (20  μg/bottle), clothianidin (90  μg/bottle), 
and chlorfenapyr (100  μg/bottle) at the diagnostic dose. 
Stock solutions for all insecticides and synergists were 
prepared using 95–98% ethanol as a solvent for all, clothi-
anidin also included 58.8 μg Mero (Sigma-Aldrich, USA), 
to circumvent issues previously experienced with bottle 
coating and insecticide crystallization. Approximately 
20–25 mosquitoes were introduced into each assay bot-
tle and mortality was recorded in all bottles at the start 
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Fig. 1 Map of study sites in Faranah Prefecture, Guinea. Human landing catches (HLCs) were performed in the villages of Balayani, Foulaya and 
Tindo to collect adult An. gambiae s.l. Larval collections were undertaken at multiple sites in the city of Faranah
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of the assay and at 15-min intervals for up to 30 min (for 
alpha-cypermethrin, deltamethrin, permethrin, bendio-
carb, and pirimiphos-methyl) or 60 min (for clothianidin 
and chlorfenapyr). Mosquitoes exposed to chlorfenapyr 
were held for an additional 24  h in paper cups, with 
access to 10% sugar solution. In each bioassay, a control 
bottle, coated with 98% ethanol, was run in parallel. Mor-
tality was defined as the inability of a mosquito to stand 
or fly in a coordinated manner [11]. Synergist CDC bot-
tle bioassays were performed using piperonyl butoxide 
(PBO) to investigate the potential role of detoxifying 
enzyme families in resistance. Bottles were coated with 
100 μg of PBO and mosquitoes were exposed for 60 min, 
followed by exposure to pyrethroid treated bottles. Adult 
mosquitoes reared from larvae were exposed for 30 min 
to permethrin and deltamethrin for comparison to wild 
caught adults. Multiple replicates were performed per 
insecticide and study village. When limited by mosquito 
availability, for insecticides where there was a clear lack 
of resistance, i.e. 100% of exposed mosquitoes dying/
becoming knocked-down very quickly into the exposure 
period, priority was given to testing remaining mosqui-
toes with doses of insecticides where initial resistance 
to the diagnostic dose was observed. At the end of each 
exposure period, separate individual surviving (resist-
ant), knocked-down or dead (susceptible), and control 
mosquitoes were dipped in ethanol and then preserved 
in  RNAlater® (Thermo Fisher Scientific, UK) at 4  °C in 
Faranah, for a maximum of 3 weeks, and subsequently at 
− 80  °C for downstream molecular analyses at the Lon-
don School of Hygiene and Tropical Medicine (LSHTM).
RNA extraction
Single mosquitoes were homogenized using a Qiagen Tis-
sue Lyser II (Qiagen, Hilden, Germany) with 3 mm stain-
less steel beads and RNA was extracted using Qiagen 96 
RNeasy Kits according to the manufacturer’s instructions 
(Qiagen, Hilden, Germany). RNA was eluted in 45 μL of 
RNase-free water and stored at − 70 °C. Specimens were 
selected from all three study villages, including repre-
sentative susceptible and resistant individuals per insec-
ticide per concentration. A High Capacity cDNA Reverse 
Transcription kit (Applied Biosystems) was used to per-
form reverse transcription on eluted RNA. Reactions 
were performed in a Bio-Rad T100™ Thermal Cycler 
which cycled for 10 min at 25 °C, 120 min at 37 °C, and 
5  min at 85  °C. The resulting cDNA was then stored at 
− 20 °C.
Identification of Anopheles gambiae species complex
Mosquitoes were morphologically identified as Anoph-
eles gambiae sensu lato (s.l.) in the field prior to CDC 
bottle bioassay testing. A sub-set of 480 samples were 
further identified using an end point PCR assay devel-
oped by Santolamazza et al. [12]. This assay amplifies the 
SINE200 insertion, a highly repetitive ~ 200  bp element 
which is widespread in the An. gambiae sensu stricto 
(s.s.) genome [12]. Samples were prepared with forward 
(5′-TCG CCT TAG ACC TTG CGT TA-3′) and reverse 
(5′-CGC TTC AAG AAT TCG AGA TAC-3′) primers, and 
amplifications performed in 20  µL reactions containing 
2 µL cDNA, 2 µL of each primer (10 µM), 4 µL  H2O, and 
10 µL 2× Hot Start Taq PCR Master Mix (New England 
Biolabs). The cycling conditions in the Bio-Rad T100™ 
Thermal Cycler were: 10 min at 94  °C; 35 cycles of 30 s 
at 94 °C, 30 s at 54 °C, and 60 s at 72 °C; then 10 min at 
72  °C. Products were run on 2% agarose gels in an Inv-
itrogen E-gel iBase™ Real-Time Transilluminator. Ampli-
fication products of 479  bp or 249  bp were considered 
indicative of Anopheles coluzzii or An. gambiae s.s., 
respectively; both bands indicate a hybrid individual. The 
An. gambiae s.s. form has an identical banding pattern to 
that of Anopheles melas and Anopheles quadriannula-
tus (249  bp), however, due to the geographical location 
of sampling, it is highly unlikely that these species were 
present.
Plasmodium falciparum detection
A total of 508 whole body mosquito samples (collected 
in HLCs) were tested for the presence of P. falciparum 
using a real-time assay targeting the cytochrome c oxi-
dase subunit 1 (cox1) mitochondrial gene of P. falciparum 
according to Boissière et al. [13]. This sample includes all 
specimens which underwent PCR for species identifica-
tion and were subsequently processed for metabolic gene 
expression (see below). This assay is highly sensitive and 
specific, capable of detecting the target gene at all stages 
of the P. falciparum life cycle [13]. Samples were prepared 
with forward (5′-TTA CAT CAG GAA TGT TAT TGC-3′) 
and reverse (5′-ATA TTG GAT CTC CTG CAA AT-3′) prim-
ers, and amplifications performed in 10 µL reactions con-
taining 2  µL cDNA, 1  µL of each primer (10  µM), 1  µL 
 H2O, and 5 µL 2× Roche FastStart Essential DNA green 
master mix containing SYBR Green. Samples were run 
on a Roche  Lightcycler® 96 Real-Time PCR system for 
15 min at 95 °C, followed by 35 cycles of 15 s at 95 °C and 
30  s at 58  °C. Fluorescence results were analysed using 
Roche  Lightcycler® 96 software. Positive controls were 
used from gDNA extracted from a cultured P. falciparum-
infected blood sample (parasitaemia of ~ 10%) in addition 
to the inclusion of no template controls (NTCs).
Characterization of resistance mutations: target site 
mutations
A sub-sample of 60 mosquitoes was selected to be tested 
for the West African L1014F kdr mutation, given the high 
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frequency of this allele and its fixation in many parts of 
Guinea and West Africa [10, 14]. The PCR master mix 
was prepared according to MR4 guidelines [15]. Prim-
ers IPCF (5′-GAT AAT GTG GAT AGA TTC CCC GAC 
CATG-3′), AltRev (5′-TGC CGT TGG TGC AGA CAA 
GGATG-3′), WEST WT (5′-GGT CCA TGT TAA TTT 
GCA TTA CTT ACG AAT A-3′), and West:West (5′-CTT 
GGC CAC TGT AGT GAT AGG AAA TGTT-3′) were used 
to detect the L1014F allele. Amplifications were per-
formed in 25 µL reactions containing 2 µL cDNA, 1 µL 
IPCF (2.5  pmol/µL), 1  µL AltRev (2.5  pmol/µL), 1  µL 
West WT (25.0 pmol/µL), 3 µL West:West (8.0 pmol/µL), 
4.5 µL  H2O, and 12.5 µL 2× Hot Start Taq PCR Master 
Mix (New England Biolabs). Samples were run on a Bio-
Rad T100™ Thermal Cycler and cycled for 5 min at 95 °C, 
followed by 35 cycles of 30 s at 95 °C, 30 s at 59 °C, and 
30 s at 72 °C, and a final extension step of 5 min at 72 °C. 
PCR products were separated on 2% agarose gels in an 
Invitrogen E-gel iBase™ Real-Time Transilluminator. A 
control band at 314 bp indicated a successful reaction, a 
band at 214 bp indicated the susceptible wild type, and a 
band at 156 bp indicated the resistance mutation.
Detection of the N1575Y mutation was carried out 
with 570 samples (including the 60 individuals who tested 
positive for L1014F kdr), using a TaqMan PCR assay 
developed by Jones et  al. [16]. Forward primer (5′-TGG 
ATC GCT AGA AAT GTT CAT GAC A-3′), reverse primer 
(5′-CGA GGA ATT GCC TTT AGA GGT TTC T-3′), and 
two probes: Yprobe (5′- TTT TTC ATT GCA TAA TAG 
TAC-3′) and Nprobe (5′-ATT TTT TTC ATT GCA TTA 
TAG TAC -3′) were used to detect the presence of the wild 
type and the mutation allele. HEX and FAM fluorophores 
were used due to their different excitation wavelengths, 
ensuring no interference: excitation of HEX showed no 
mutation, while excitation of HEX and FAM at similar Ct 
values indicated the N1575Y mutation. 20  µL reactions 
containing 2 µL cDNA, 1 µL each primer (10 µM), 0.5 µL 
each probe, 5 µL  H2O, and 10 µL QuantiTect Probe Mas-
ter Mix were prepared in plates and run on an Agilent 
Technologies Stratagene Mx3005P qPCR system and 
cycled according to the Quantitect™ Probe PCR Hand-
book guidelines (15 min at 95 °C; 35 cycles of 15 s at 95 °C 
and 60 s at 60 °C). Positive controls from gDNA extracted 
from known An. gambiae s.s. with the N1575Y mutation 
and without the mutation were included on each run in 
addition to no template controls (NTCs).
A subsample of 30 mosquitoes which were resistant or 
susceptible to bendiocarb were tested for the presence of 
the G119S Ace-1 mutation using a TaqMan PCR assay, 
according to Weill et al. [17]. Samples were prepared with 
degenerate primers Moustdir1 (5′-CCGGGNGCSACY 
ATG TGGAA-3′) and Moustrev1 (5′-ACGATMACG 
TTC TCY TCC GA-3′), and amplifications performed 
in 20  µL reactions containing 2  µL cDNA, 2  µL each 
primer (10 µM), 4 µL  H2O, and 10 µL 2× Hot Start Taq 
PCR Master Mix (New England Biolabs). Samples were 
loaded into a Biorad T100™ Thermal Cycler for 3 min at 
95 °C, followed by 30 cycles of 30 s at 95 °C, 30 s at 52 °C, 
and 1 min at 72  °C, and a final step of 10 min at 72  °C. 
The resulting PCR fragments were then digested with 
AluI restriction enzyme (Thermo Scientific) for 16  h, 
according to the manufacturer’s instructions, and run 
on 2% agarose gels in an Invitrogen E-gel iBase™ Real-
Time Transilluminator. 194 bp undigested PCR products 
indicated the susceptible allele and 74  bp and 120  bp 
digested fragments indicated the presence of the resist-
ant allele. Presence of all three product sizes indicated 
the sample was heterozygous. Positive controls from 
gDNA extracted from known An. gambiae s.s. that were 
homozygous susceptible (SS), homozygous resistant (RR) 
and heterozygous individuals (RS) for G119S Ace-1 were 
included in addition to no template controls (NTCs).
Characterization of resistance mechanisms: metabolic 
gene expression
The relative gene expression of two cytochrome-
dependent monooxygenases: CYP6P3, CYP6M2, and 
glutathione-s-transferase, GSTD3, was analysed in 461 
individuals from Guinea and 41 susceptible G3 individu-
als from a colony at LSHTM, using quantitative reverse 
transcriptase PCR (qRT-PCR) relative to the house-
keeping gene ribosomal protein S7 (RPS7), according 
to Yahouédo et al. [18]. RPS7 was selected as an endog-
enous reference gene, commonly used to normalize RNA 
expression levels, between Anopheles populations. These 
genes were targeted based upon their significant overex-
pression in other neighbouring West African vector pop-
ulations [18, 19]. Each gene used the following primers: 
RPS7 forward (5′-ATT GCC GAG CGC CGC ATT CT-3′) 
and reverse (5′-GAC GCG GAT ACG CTT GCC GA-3′) 
primers, CYP6M2 forward (5′-TCG GGA TGT GTG CGT 
TCG GC-3′) and reverse (5′-TCG TGT CTC GCA CCG 
CGT TC-3′) primers, CYP6P3 forward (5′-TGT GAT TGA 
CGA AAC CCT TCG GAA G-3′) and reverse (5′-ATA GTC 
CAC AGA CGG TAC GCGGG-3′) primers, and GSTD3 
forward (5′-CTA AGC TTA ATC CGC AAC ATA CCA -3′) 
and reverse (5′-GTG TCA TCC TTG CCG TAC AC-3′) 
primers. For each gene, 10  µL reactions were prepared 
containing 2 µL cDNA, 1 µL each primer (10 µM), 1 µL 
 H2O, and 5 µL 2× Roche FastStart Essential DNA green 
master mix containing SYBR Green. Prepared reac-
tions were loaded into the Agilent Technologies Strata-
gene Mx3005P qPCR system which cycled for 10 min at 
95  °C; 35 cycles of 10 s at 95  °C, 22 s at 60  °C, and 10 s 
at 72  °C; followed by a melt curve. Serial dilutions were 
performed on selected samples for each of the four genes 
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and relative standard curves produced using the Strata-
gene MxPro qPCR software (Agilent Technologies). 
Using the same software, sample Ct values could then be 
used to generate relative quantities, accounting for each 
assays’ efficiency, and the expression level of each meta-
bolic gene tested could be normalized to the housekeep-
ing gene RPS7.
Data analysis
Data were recorded on pre-prepared data sheets and 
entered into an Excel spreadsheet. Control mortality 
in bioassays never exceeded 5%, thus correction using 
Abbott’s formula was not necessary. Mosquito mortal-
ity was analysed according to WHO criteria: 98–100% 
mortality at 30  min of exposure indicates ‘susceptibil-
ity’, 90–97% mortality suggests ‘possible resistance’ and 
< 90% indicates the presence of ‘resistance’ [4]. Graph-
Pad Prism 7 (GraphPad Software) was used for statisti-
cal analysis (t-tests, Fisher’s exact tests and Chi-squared 
tests). Microsoft Excel was used to calculate proportions 
and construct resistance graphs. Stratagene MxPro qPCR 
software (Agilent Technologies) was used to produce rel-
ative standard curves for genotypic analysis.
Results
Mosquito collections and species identification
A total of 2597 female An. gambiae s.l. mosquitoes were 
either wild-caught using HLCs from three villages in 
Faranah Prefecture (Balayani = 956, Foulaya = 914, and 
Tindo = 589) or raised from larvae collected in Faranah 
(n = 138). Of those, 480 were selected for molecular spe-
cies identification, with 466 (97.1%) determined to be 
An. gambiae s.s., 6 (1.3%) identified as An. coluzzii, and 6 
(1.3%) identified as hybrids; results were inconclusive for 
2 (0.4%) individuals.
Insecticide resistance intensity
Levels of susceptibility to seven insecticides (perme-
thrin, deltamethrin, alpha-cypermethrin, bendiocarb, 
pirimiphos-methyl, clothianidin and chlorfenapyr) 
were assessed across three villages in Faranah (Balayani, 
Foulaya, and Tindo). Overall, each study site displayed 
comparable resistance profiles for deltamethrin (pyre-
throid) and bendiocarb (carbamate); no significant asso-
ciation between mosquito mortality and sample site was 
observed (χ2 = 6.495, p = 0.0899 for deltamethrin 1×; 
χ2 = 1.338, p = 0.5122, χ2 = 2.38, p = 0.304 and χ2 = 0.903, 
p = 0.637 for bendiocarb at 1×, 2× and 5×, respectively). 
However, mosquito mortality following permethrin 
(pyrethroid) exposure varied among villages in Faranah 
(χ2 = 8.573, p = 0.035 and χ2 = 29.58, p < 0.0001, for 1× 
and 2×, respectively).
Considering HLC-collected adult mosquitoes from 
Faranah Prefecture as a whole, resistance was consist-
ently observed to permethrin and deltamethrin. Perme-
thrin gave the lowest mortality of all insecticides tested 
with 4% [95% CI 1%, 11%] and 15% [95% CI 9%, 24%] 
mosquito mortality at 1× and 2× the diagnostic doses, 
respectively (Fig. 2 and Table 1). Resistance to deltame-
thrin was also evident, but to a lesser degree; average 
mosquito mortality to the diagnostic dose was 86% [95% 
CI 77%, 91%] (Fig. 2). Possible resistance was observed to 
bendiocarb, with mosquito mortality ranging between 94 
and 97% at 1×, 2×, and 5× concentrations. Mosquitoes 
were found to be susceptible to the diagnostic doses of all 
other insecticides with mortalities > 98% for alpha-cyper-
methrin, chlorfenapyr, clothianidin, and pirimiphos-
methyl (Fig. 2 and Table 1). 
Minor variations in levels of resistance were apparent 
between study villages. The most intense permethrin 
resistance was measured in Foulaya, with average mos-
quito mortality of 0% [95% CI 0%, 13%] following expo-
sure to either 1× or 2× the diagnostic dose, relative to 
6% [95% CI 2%, 19%] and 10% [95% CI 4%, 24%] in Bal-
ayani and 7% [95% CI 1%, 30%] and 43% [95% CI 24%, 
63%] in Tindo, respectively (Table 1). Possible resistance 
to permethrin 5× was identified in Foulaya and Balayani 
(average mosquito mortality of 96% [95% CI 81%, 99%] 
and 97% [95% CI 87%, 100%], respectively). By compari-
son, the lowest levels of resistance to the diagnostic dose 
of deltamethrin were observed in Foulaya, with average 
mosquito mortality of 95% [95% CI 84%, 99%], compared 
to 79% [95% CI 62%, 89%] and 75% [95% CI 51%, 90%] in 
Balayani and Tindo, respectively.
Two to five-day old mosquitoes raised in the insectary 
from larvae demonstrated moderately similar resistance 
profiles, when compared to locally-collected adult popu-
lations of varying physiological age (Table  1). Both per-
methrin and deltamethrin resistance was present, with 
average mosquito mortality of 21% [95% CI 10%, 40%] 
and 60% [95% CI 36%, 80%] for permethrin 1× and 2× 
doses, respectively, and 73% [95% CI 43%, 90%] mortal-
ity for deltamethrin 1×. Comparing resistance profiles 
in larvae to that observed in each village, a statistical 
difference was observed for permethrin 1× in Foulaya 
(χ2 = 6.014, p = 0.0142) and in all villages combined 
at 1× (χ2 = 7.407, p = 0.0065); permethrin 2× in Bal-
ayani (χ2 = 14.62, p = 0.0001) and Foulaya (χ2 = 20.753, 
p < 0.0001), and all villages combined at 2× (χ2 = 15.2, 
p = 0.0001); and deltamethrin 1× in Foulaya (χ2 = 4.72, 
p = 0.0298). Reared mosquitoes were found to be suscep-
tible to all other concentrations of permethrin and del-
tamethrin with mortalities of 100%.
Synergist bioassays were performed on a sub-sam-
ple of mosquitoes from Balayani. Pre-exposure to PBO 
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and subsequent permethrin or deltamethrin treatment 
resulted in partial or complete abolishment of resistance. 
Mortality to permethrin increased from 6 to 87% at 1×, 
and from 10 to 100% at 2×; mortality following deltame-
thrin exposure increased from 79 to 100% at 1×.
Plasmodium falciparum detection
Of the 508 mosquitoes tested for the presence of P. fal-
ciparum, 37 individuals were positive (indicating the 
presence of any parasite lifecycle stage), giving an infec-
tion rate of 7.3%. For PCR-confirmed An. gambiae s.s., P. 
falciparum infection prevalence was 6.1% (26/423). There 
was no significant difference in P. falciparum infection 
among study villages (χ2 = 1.358, p = 0.507). Considering 
pooled insecticide results (permethrin, deltamethrin, and 
bendiocarb), susceptible mosquitoes were more likely to 
be infected with P. falciparum (7.6%; 33/432) than resist-
ant mosquitoes (2.8%; 4/144) (χ2 = 4.236, p = 0.039). 
However, no statistical association between survival to 
insecticide exposure and P. falciparum infection was 
observed per individual chemical (Fisher’s exact: perme-
thrin 2× p = 0.37, 5× p = 0.54; deltamethrin 1× p = 0.43; 
bendiocarb 1× p = 0.58, 2× p = 0.73, 5× p = 0.6 and 10× 
p = 0.54).
Characterization of resistance mechanisms: target site 
mutations
Of the sub-sample of 60 An. gambiae s.s. which were 
tested for the L1014F kdr allele, this mutation was 
identified in all An. gambiae s.s. samples (100%). Of 
the 570 individuals which were assayed for the pres-
ence of N1575Y, this mutation was detected in 20% 
(113/561; 9 specimens failed to amplify) (Table 2). For 
PCR-confirmed An. gambiae s.s., N1575Y was observed 
in 19% (91/473) of specimens. Four (0.7%) individuals 
were heterozygous for this mutation, while the remain-
der were homozygous. Across Faranah, the frequency 
of N1575Y did not vary significantly (χ2 = 4.4819, 
p = 0.214 for comparisons between Balayani, Fou-
laya, Tindo, and larvae from Faranah). In addition, 
no significant association was observed between the 
presence of the N1575Y mutation and the ability to 
survive exposure to pyrethroid insecticides (perme-
thrin 1× χ2 = 0.015, p = 0.902; 2× χ2 = 0.189, p = 0.664; 
5× χ2 = 0.814, p = 0.359; deltamethrin 1× χ2 = 0.934, 
p = 0.334). Significant deviations from Hardy–Wein-
berg equilibrium were observed in almost all phe-
notyped specimens, indicative of ongoing selection 
(Table 2).
Fig. 2 Pooled CDC resistance intensity assay data for all tested insecticides (permethrin, deltamethrin, alpha-cypermethrin, bendiocarb, 
pirimiphos-methyl, clothianidin and chlorfenapyr) in Faranah Prefecture, Guinea for adult wild-caught mosquitoes. Mortality below 90% indicates 
the presence of confirmed resistance. *Only tested at diagnostic dose
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Of the subsample of 30 An. gambiae s.s. which sur-
vived or died following bendiocarb exposure, the G119S 
Ace-1 mutation was present in 62% (18/29 individuals; 1 
specimen failed to amplify) (Table 3), with allele frequen-
cies ranging from 0.25 to 1.0. Seventeen specimens were 
homozygous, the remaining individual was heterozygous. 
There was a statistically significant association between 
the presence of the G119S Ace-1 mutation and mosquito 
survival after bendiocarb exposure at 1× and 2× (Fisher’s 
exact: p = 0.00108 and p = 0.0238 respectively). Signifi-
cant deviations from Hardy–Weinberg equilibrium for 
G119S Ace-1, were limited to mosquitoes which died fol-
lowing exposure to bendiocarb 2× and 5× (Table 3).
Characterization of resistance mechanisms: metabolic 
gene expression
461 samples identified as An. gambiae s.s. were tested 
for the expression of CYP6M2, CYP6P3, and GSTD3 
genes relative to the housekeeping gene RPS7 and com-
pared to 41 An. gambiae s.s. samples from a susceptible 
G3 colony. These three genes were significantly overex-
pressed in the majority of wild-caught An. gambiae s.s. 
when compared to the susceptible G3 laboratory strain 
(Table 4 and Fig. 3).
The greatest changes in gene expression were 
observed for GSTD3, with an average mean fold change 
of 1.19 among wild An. gambiae s.s. compared to 0.44 
in G3 colony individuals; average levels of CYP6M2 
and CYP6P3 were 0.84 and 0.79 compared to 0.09 and 
0.12 between field and colony mosquitoes, respec-
tively. Among Guinean vectors, a significantly higher 
expression of CYP6P3 was observed between individu-
als which survived bendiocarb exposure at 1× and 2×, 
compared to those that died (1.44 vs. 0.62; p = 0.0524 
and 1.68 vs. 0.55; p = 0.0366, respectively) (Table  4). 
However, no significant changes in gene expression of 
CYP6M2 and GSTD3 were apparent between wild An. 
gambiae s.s. which survived or died after insecticide 
exposure at any dose.
Table 1 Percentage mortality (and numbers tested) of  Anopheles gambiae s.l. in  CDC resistance intensity assays 
conducted at four sites in Faranah Prefecture, Guinea
Study site Insecticide % Mortality (numbers tested) after diagnostic time
1× 2× 5× 10×
Balayani Permethrin 6% (34) 10% (39) 97% (38) 100% (55)
Permethrin + PBO 87% (15) 100% (18) 100% (22) 100% (28)
Deltamethrin 79% (33) 100% (35) 100% (32) 100% (46)
Deltamethrin + PBO 100% (26) – – –
Alpha-cypermethrin 100% (20) – – –
Bendiocarb 97% (38) 98% (42) 96% (46) 100% (43)
Pirimiphos-methyl 100% (40) – – –
Clothianidin 100% (38) – – –
Chlorfenapyr 100% (21) – – –
Foulaya Permethrin 0% (26) 0% (28) 96% (25) 100% (24)
Deltamethrin 95% (41) 100% (39) 100% (41) 100% (24)
Alpha-cypermethrin 100% (42) – – –
Bendiocarb 92% (48) 93% (43) 96% (53) 100% (47)
Pirimiphos-methyl 100% (19) – – –
Clothianidin 100% (33) – – –
Chlorfenapyr 100% (40) – – –
Tindo Permethrin 7% (15) 43% (21) 100% (20) 100% (29)
Deltamethrin 75% (16) 100% (15) 100% (17) 100% (17)
Alpha-cypermethrin 100% (41) – – –
Bendiocarb 95% (21) 100% (23) 100% (21) 95% (21)
Pirimiphos-methyl 100% (38) – – –
Clothianidin 100% (53) – – –
Chlorfenapyr 100% (40) – – –
Faranah Permethrin 21% (28) 60% (15) 100% (12) 100% (17)
Larvae Deltamethrin 73% (11) 100% (11) 100% (13) 100% (14)
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Table 2 N1575Y allele frequencies and  p values for  Chi-square tests for  deviations from  Hardy–Weinberg equilibrium 
in An. gambiae s.s. from four sites in Faranah Prefecture, Guinea
Study village/sampling site
Balayani Foulaya Tindo Larvae
RS RR SS RS RR SS RS RR SS RS RR SS
Permethrin 1×
 Alive 0 2 14 0 3 7 0 4 7 0 1 11
 Dead 0 0 2 0 0 0 0 0 1 0 2 4
Permethrin 2×
 Alive 0 2 22 0 2 12 0 2 10 0 0 6
 Dead 0 0 3 0 0 0 0 3 6 0 0 9
Permethrin 5×
 Alive 0 1 0 0 0 1 0 0 0 0 0 0
 Dead 0 4 12 0 0 4 0 2 10 0 3 6
Permethrin 10×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 3 6 0 0 4 0 3 2 0 0 4
Deltamethrin 1×
 Alive 0 2 4 0 0 2 0 2 2 0 1 2
 Dead 0 2 13 0 2 9 0 4 8 0 1 4
Deltamethrin 2×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 1 7 0 2 6 0 1 2 0 1 4
Deltamethrin 5×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 1 10 0 1 5 0 1 2 0 2 2
Deltamethrin 10×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 2 6 0 2 3 0 1 5 0 1 4
Alpha-cypermethrin 1×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 2 3 0 0 9 0 4 6 0 0 0
Alpha-cypermethrin 2×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 1 0 4 0 4 7 0 1 7 0 0 0
Alpha-cypermethrin 5×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 1 5 0 3 14 0 0 0 0 0 0
Alpha-cypermethrin 10×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0
 Dead 0 0 0 1 3 20 0 0 0 0 0 0
Bendiocarb 1×
 Alive 0 4 1 0 0 0 0 0 1 0 0 0
 Dead 0 3 17 0 2 8 0 1 2 0 0 0
Bendiocarb 2×
 Alive 0 0 1 0 1 2 0 0 0 0 0 0
 Dead 1 5 13 0 1 9 0 0 4 0 0 0
Bendiocarb 5×
 Alive 0 0 2 0 0 2 0 0 0 0 0 0
 Dead 0 4 17 1 0 7 0 0 3 0 0 0
Bendiocarb 10×
 Alive 0 0 0 0 0 0 0 1 0 0 0 0
 Dead 0 0 9 0 0 10 0 0 4 0 0 0
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Italic values indicate significance of p values (p < 0.05)
Table 2 (continued)
Study village/sampling site N1575Y allele frequency χ2 test p value
Total
RS RR SS R S
Permethrin 1×
 Alive 0 10 39 0.2 0.8 49 < 0.00001
 Dead 0 2 7 0.22 0.78 9 0.0027
Permethrin 2×
 Alive 0 6 50 0.11 0.89 56 < 0.00001
 Dead 0 3 18 0.14 0.86 21 < 0.00001
Permethrin 5×
 Alive 0 1 1 0.5 0.5 2 0.157299
 Dead 0 9 32 0.22 0.78 41 < 0.00001
Permethrin 10×
 Alive 0 0 0 – – – –
 Dead 0 6 16 0.27 0.73 22 < 0.00001
Deltamethrin 1×
 Alive 0 5 10 0.33 0.67 15 0.00108
 Dead 0 9 34 0.21 0.79 43 < 0.00001
Deltamethrin 2×
 Alive 0 0 0 – – – –
 Dead 0 5 19 0.21 0.79 24 < 0.00001
Deltamethrin 5×
 Alive 0 0 0 – – – –
 Dead 0 5 19 0.21 0.79 24 < 0.00001
Deltamethrin 10×
 Alive 0 0 0 – – – –
 Dead 0 6 18 0.25 0.75 23 < 0.00001
Alpha-cypermethrin 1×
 Alive 0 0 0 – – – –
 Dead 0 6 18 0.25 0.75 23 < 0.00001
Alpha-cypermethrin 2×
 Alive 0 0 0 – – – –
 Dead 1 5 18 0.23 0.77 18.6729 0.000016
Alpha-cypermethrin 5×
 Alive 0 0 0 – – – –
 Dead 0 4 19 0.17 0.83 23 < 0.00001
Alpha-cypermethrin 10×
 Alive 0 0 0 – – – –
 Dead 1 3 20 0.15 0.85 16.6434 0.000045
Bendiocarb 1×
 Alive 0 4 2 0.67 0.33 6
 Dead 0 6 27 0.18 0.82 33
Bendiocarb 2×
 Alive 0 1 3 0.25 0.75 4
 Dead 1 6 26 0.2 0.8 29.9806 < 0.00001
Bendiocarb 5×
 Alive 0 0 4 0 1 – –
 Dead 1 4 27 0.14 0.86 24.2602 < 0.00001
Bendiocarb 10×
 Alive 0 1 0 1 0 – –
 Dead 0 0 23 0 1 – –
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Discussion
The susceptibility of An. gambiae s.l. populations from 
Faranah, Guinea to seven public health insecticides 
were assessed and underlying resistance mechanisms 
characterized. Intense resistance to permethrin and 
deltamethrin was apparent, with survivors at 5× and 
2× the diagnostic doses, respectively; minor hetero-
geneity in mosquito mortality was also evident across 
this restricted geographic area. By comparison, no evi-
dence of alpha-cypermethrin resistance was observed 
in Faranah, with 100% mosquito mortality follow-
ing exposure. Increased tolerance to particular pyre-
throids in this region is not unexpected, given LLINs 
are the sole insecticide-based malaria control strategy 
implemented in Guinea. Deltamethrin LLINs were dis-
tributed nationwide in 2013  (Netprotect®) and 2016 
 (PermaNet® 2.0 and  Yorkool®) by the National Malaria 
Control Programme (NMCP) [10], thus a resulting 
increase in deltamethrin resistance would be antici-
pated. However, the higher levels of permethrin resist-
ance demonstrated in this study could be the result 
of control efforts prior to 2013 or concurrent use of 
this insecticide (and/or others capable of facilitating 
cross-resistance) in agriculture activities. Alternatively, 
L1014F kdr, which our study indicated was fixed in Far-
anah in 2018, as well as in other parts of Guinea [10, 
20], has been reported to contribute more to resistance 
to type I (permethrin) vs type II (alpha-cypermethrin 
and deltamethrin) pyrethroids [21].
In Faranah, susceptibility to all other classes of insec-
ticides under evaluation was confirmed, excluding the 
carbamate, bendiocarb, which showed the development 
of possible resistance with mortality ranging between 
94 and 97% in the region. This emerging resistance may 
also be attributable to carbamate use in the agricultural 
setting [10], as has been documented previously in other 
parts of Guinea [20]. The organophosphate, pirimiphos-
methyl, achieved complete mosquito mortality in this 
study. Currently, large-scale government-funded, wide-
spread IRS activities are not underway in Guinea. How-
ever, knowledge of susceptibility in relation to  current 
LLIN use will help to guide potential IRS implementa-
tion in the future [9]. Local mosquito populations were 
also susceptible to two new insecticides under considera-
tion for public health use, clothianidin (neonicotinoid) 
and chlorfenapyr (pyrrole), strengthening the evidence 
that net impregnations and IRS formulations with these 
insecticides may be successful in future vector control 
efforts. Likewise, absence of alpha-cypermethrin resist-
ance supports the deployment of Interceptor  G2® LLINs 
(containing a combination of alpha-cypermethrin and 
chlorfenapyr) in prospective LLIN distributions.
Regarding underlying resistance mechanisms, 
decreased susceptibility to pyrethroids in Faranah was 
mediated both by target site mutations and overexpres-
sion of metabolic enzymes. The L1014F kdr mutation 
was detected in all tested samples, which is consistent 
with high frequencies of this mutation observed through-
out the country [10, 20]. This study did not screen for 
the East African L1014S kdr mutation, which is known 
to have variable frequencies in West Africa and may 
warrant surveillance in Guinea in the future [22–24]. A 
Table 3 G119S Ace-1 allele frequencies and  p values for  Chi-square tests for  deviations from  Hardy–Weinberg 
equilibrium in An. gambiae s.s. from four sites in Faranah Prefecture, Guinea
Italic values indicate significance of p values (p < 0.05)
Study village/sampling site G119S Ace-1 
allele frequency
χ2 test p-value
Balayani Foulaya Tindo Larvae
RS RR SS RS RR SS RS RR SS RS RR SS R S
Bendiocarb 1×
 Alive 0 1 0 0 4 0 0 1 0 0 6 0 1 0 – –
 Dead 0 0 5 0 0 0 0 0 0 0 0 5 0 1 – –
Bendiocarb 2×
 Alive 0 1 0 0 4 0 0 0 0 0 5 0 1 0 – –
 Dead 0 1 1 0 0 1 0 0 1 0 1 3 0.25 0.75 4 0.0455
Bendiocarb 5×
 Alive 0 2 0 1 0 0 0 0 0 1 2 0 0.83 0.17 0.12 0.729034
 Dead 0 2 2 0 0 0 0 0 0 0 2 2 0.5 0.5 4 0.0455
Bendiocarb 10×
 Alive 0 0 0 0 0 0 0 0 0 0 0 0 – – – –
 Dead 0 0 0 0 0 1 0 1 0 0 1 1 0.5 0.5 2 0.157299
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second mutation in the voltage-gated sodium channel, 
N1575Y, was confirmed in 20% of vectors, with strong 
evidence for ongoing selection, as demonstrated by sig-
nificant deviations from Hardy–Weinberg allele frequen-
cies; however this mutation was not associated with 
mosquito survival following insecticide exposure. A syn-
ergistic relationship between the L1014F kdr and N1575Y 
mutations has been established in other parts of West 
Africa, where it has been shown to enhance resistance 
to pyrethroids and DDT, and potentially compensate for 
fitness costs incurred by L1014F kdr [16]. By compari-
son, in Maferinyah, Guinea, this mutation was present at 
similar frequencies to Faranah and directly implicated in 
phenotypic resistance to permethrin [20].
The ability of the synergist PBO to re-establish full or 
partial susceptibility to both permethrin and deltame-
thrin indicates that mixed-function oxidases (MFOs) 
play some role in the resistance reported. However, the 
expression of metabolic enzymes examined in this study 
(CYP6M2, CYP6P3, and GSTD3), while significantly 
upregulated in wild An. gambiae s.s. compared to the sus-
ceptible G3 colony, did not statistically differ between our 
pyrethroid resistant and susceptible wild-caught mos-
quitoes. Further exploratory analyses of our wild popula-
tions are warranted to characterize additional metabolic 
resistance pathways. Given the influence of MFOs as a 
predominant resistance mechanism to pyrethroids in 
the area and recent findings of improved protection with 
permethrin and PBO impregnated nets [25], the Guinea 
NMCP should consider including these next-generation 
nets in future vector control activities.
The G119S Ace-1 mutation, which confers resistance 
to carbamate and organophosphate insecticides [17] was 
found in this study to be highly predictive of bioassay 
survival to bendiocarb. Furthermore, CYP6P3 was signif-
icantly overexpressed in bendiocarb survivors, suggesting 
it may also be responsible for decreased susceptibility to 
carbamates in Faranah. Similar results implicating a role 
for CYP6P3 in bendiocarb metabolism and resistance 
have been reported from Côte d’Ivoire [26] and over-
expression of this CYP450 has been documented among 
many multi-insecticide resistant field populations [5, 
27–30].
In this study, mosquitoes that were reared from lar-
vae collected from sites in the town of Faranah showed 
a higher mortality rate to permethrin at 1× and 2× the 
diagnostic dose, when compared to the wild-caught adult 
population of varying physiological age. This finding 
contradicts previous studies which have suggested that 
field-collected adults have higher mortality rates due to 
the mixture of ages and blood-feeding statuses in these 
populations [31], and the reported decline of pheno-
typic resistance with increasing mosquito age [32]. This 
observation strengthens the importance of utilizing the 
same methods of  mosquito collection and assay prepa-
ration when testing field-collected mosquitoes [31] and 
cautions against the use of such data interchangeably. 
Because mosquito availability was a limiting factor, test-
ing priority for replicates was given to insecticides where 
initial resistance was observed to the diagnostic dose, 
to more accurately characterize levels of phenotypic 
resistance intensity. Additional bioassay testing of larger 
samples sizes is required to corroborate these results in 
Faranah.
Malaria prevalence in Faranah Prefecture is approxi-
mately 15%, reaching up to 25% [8]; mosquito infection 
rates in this study were 7.3%. Because whole mosquito 
bodies were screened for P. falciparum by PCR, it is also 
possible that, in addition to infection or infectivity, a 
positive sample could be indicative of a mosquito which 
recently fed upon an infected human blood meal. More 
importantly, insecticide susceptible vectors were more 
likely to be infected with P. falciparum, but this phe-
nomenon could not be ascribed to a single insecticide or 
resistance mechanism.
Additional considerations for the interpretation of 
study data include that in the tested population of An. 
gambiae s.l., An. gambiae s.s. was the predominant spe-
cies at 97.1%, with An. coluzzii representing 1.3%, and 
the hybrid form 1.3%. Only two samples failed to pro-
duce any result on the An. gambiae complex end-point 
PCR assay. Anopheles gambiae s.s. breed in temporary, 
rain-dependent breeding sites [33], which could account 
for its predominance during the rainy season. Future 
collections at multiple timepoints, utilizing different 
collection methods would be necessary to determine 
the principal species in the area. Regarding sampling 
methodology, in this study mosquitoes were primarily 
collected using HLCs as this is often the most efficient 
technique to obtain large catches for bioassay testing. 
Due to heavy rains in the areas, larval breeding sites can 
be completely washed away, rendering this sampling 
method unpredictable. HLCs were chosen in favour 
of aspirating indoor resting, blood-fed adults and forc-
ing oviposition, to generate an  F1 population, because 
house collections frequently yield low numbers of mos-
quitoes, potentially introducing family effects as a bias. 
In addition, preference was given to testing mosquitoes 
caught in HLCs, because the latter two techniques are 
not appropriate for pathogen screening. Finally, sam-
pling took place in only three villages in one area of 
Guinea and, therefore, these findings cannot be extrapo-
lated across the entire country. However, this informa-
tion will contribute to an understanding of resistance in 
this region, which will be valuable information for the 
NMCP [34].
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Conclusions
Resistance to the pyrethroids, permethrin and deltame-
thrin, as well as possible resistance to bendiocarb were 
observed in Faranah Prefecture in Guinea. Both target 
site mutations (L1014F kdr, N1575Y and G119S Ace-1) 
and metabolic mechanisms of resistance are present 
in this field population. The complete susceptibility 
of vectors to alpha-cypermethrin, clothianidin, chlo-
rfenapyr, and pirimiphos-methyl is encouraging, and 
these insecticides should be considered by the NMCP 
in future control efforts in the form of new LLIN and 
IRS interventions as they become approved and readily 
available.
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